Furthermore, silencing CTNNB1 with the lentivirus carrying targeted CTNNB1-shRNA inhibited HCC-TCM-induced expression of CD163 on HCC-TAMs (Fig. 2i). Here, CTNNB1 is linked to hepatocellular carcinoma.